Status:
ACTIVE_NOT_RECRUITING
Survival of the Insignia Stem in Total Hip Arthroplasty
Lead Sponsor:
University of Utah
Conditions:
Primary Total Hip Arthroplasty
Eligibility:
All Genders
18-100 years
Brief Summary
The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested...
Detailed Description
Total hip arthroplasty is one of the most functionally restorative procedures in modern medicine. Since its introduction in the mid twentieth century significant advancements in implant materials have...
Eligibility Criteria
Inclusion
- Patients age ≥18
- Patients planning on undergoing primary total hip arthroplasty that will likely receive the Insignia stem and associated Stryker Acetabular Component.
- Preoperative diagnosis of osteoarthritis
- Patients willing and able to comply with follow-up requirements
- Patients willing to sign an IRB approved consent and authorization document
Exclusion
- Patients with inflammatory or pyogenic arthritis
- Body Mass Index (BMI)\>40
- Bone stock that is inadequate for support or fixation of the prosthesis
Key Trial Info
Start Date :
March 17 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05313321
Start Date
March 17 2022
End Date
March 1 2028
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Orthopaedic Center
Salt Lake City, Utah, United States, 84108